Accessibility Menu
Evome Medical Technologies logo

Evome Medical Technologies

(OTC) LNDZF

Current Price$0.00
Market Cap$100.00
Since IPO (2015)-100%
5 Year-100%
1 Year-100%
1 Month+0%

Evome Medical Technologies Financials at a Glance

Market Cap

$100.00

Revenue (TTM)

CA$48.34M

Net Income (TTM)

-CA$23.53M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

878.62 (High)

Price

$0.00

Volume

10,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

Jun 9, 2026

LNDZF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Evome Medical Technologies

Industry

Healthcare Equipment and Supplies

Employees

205

CEO

Michael D. Seckler

Headquarters

Shirley, CA 92014, US

LNDZF Financials

Key Financial Metrics (TTM)

Gross Margin

33%

Operating Margin

-24%

Net Income Margin

-24%

Return on Equity

0%

Return on Capital

-23%

Return on Assets

-10%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$100.00

Shares Outstanding

60.17M

Volume

10.00K

Avg. Volume

156.25

Financials (TTM)

Gross Profit

CA$22.53M

Operating Income

-CA$5.52M

EBITDA

-CA$10.42M

Operating Cash Flow

-CA$918.91K

Capital Expenditure

-CA$203.27K

Free Cash Flow

-CA$1.12M

Cash & ST Invst.

CA$918.68K

Total Debt

CA$24.69M

Evome Medical Technologies Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2024YOY CHG

Revenue

CA$10.01M

-49.0%

Gross Profit

CA$3.56M

-51.0%

Gross Margin

35.58%

N/A

Market Cap

$100.00

N/A

Market Cap/Employee

$0.51

N/A

Employees

195

N/A

Net Income

-CA$1.15M

-138.5%

EBITDA

CA$1.16M

-76.0%

Quarterly Fundamentals

Name
Q3 2024YOY CHG

Net Cash

-CA$16.05M

+38.5%

Accounts Receivable

CA$6.74M

-44.7%

Inventory

CA$9.26M

-23.7%

Long Term Debt

CA$4.70M

-71.0%

Short Term Debt

CA$12.77M

-36.7%

Return on Assets

-10.24%

N/A

Return on Invested Capital

-22.79%

N/A

Free Cash Flow

CA$1.76M

+994.1%

Operating Cash Flow

CA$1.79M

+1787.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ALSEAlseres Pharmaceuticals, Inc.
$0.01+100.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SQQQProShares Trust - ProShares UltraPro Short Qqq
$44.51+0.04%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.20+0.06%
KEELKeel Infrastructure
$5.28-0.03%
ONDSOndas
$9.35-0.03%

Questions About LNDZF

What is the current price of Evome Medical Technologies?

Evome Medical Technologies is trading at $0.00 per share.

What is the 52-week range for Evome Medical Technologies?

Over the past 52 weeks, Evome Medical Technologies has traded between $0.00 and $0.01.

How much debt does Evome Medical Technologies have?

As of the most recent reporting period, Evome Medical Technologies reported total debt of CA$12.93M.

How much cash does Evome Medical Technologies have on hand?

Evome Medical Technologies reported CA$1.05M in cash and cash equivalents in its most recent financial results.

What is Evome Medical Technologies’s dividend yield?

Evome Medical Technologies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.